Increasing incidence and pretransplantation screening of hepatocellular carcinoma

被引:22
作者
Everson, GT [1 ]
机构
[1] Univ Colorado, Sch Med, Denver, CO 80262 USA
关键词
D O I
10.1053/jlts.2000.1918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1. The incidence of hepatocellular cancer (HCC) in the United States and other traditionally "low-incidence" countries is increasing. 2. The rise in incidence of HCC is related to chronic hepatitis C. 3. Timely performance of liver transplantation is curative in patients with early-stage HCC. 4. Cirrhotic patients, especially those with viral hepatitis, should be screened for HCC. 5. The performance characteristics of current tests are suboptimal, but serial ultrasonography and alphafetaprotein are recommended. 6. Estimated medical charges related to screening and treatment suggest that $285,294 is required per "cured" case. Assuming that this cure is associated with a 75% to 85% chance for high-quality 10-year survival, the charges approximate $35,000 to $40,000/quality-adjusted life-year (QALY). This cost-benefit analysis is nearly identical to published rates for breast cancer screening ($30,000/ QALY).
引用
收藏
页码:S2 / S10
页数:9
相关论文
共 43 条
[1]   Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation [J].
Achkar, JP ;
Araya, V ;
Baron, RL ;
Marsh, JW ;
Dvorchik, I ;
Rakela, J .
LIVER TRANSPLANTATION AND SURGERY, 1998, 4 (06) :477-482
[2]  
AKASHI Y, 1991, HEPATOLOGY, V14, P262, DOI 10.1002/hep.1840140210
[3]   NATURAL-HISTORY OF SMALL UNTREATED HEPATOCELLULAR-CARCINOMA IN CIRRHOSIS - A MULTIVARIATE-ANALYSIS OF PROGNOSTIC FACTORS OF TUMOR-GROWTH RATE AND PATIENT SURVIVAL [J].
BARBARA, L ;
BENZI, G ;
GAIANI, S ;
FUSCONI, F ;
ZIRONI, G ;
SIRINGO, S ;
RIGAMONTI, A ;
BARBARA, C ;
GRIGIONI, W ;
MAZZIOTTI, A ;
BOLONDI, L .
HEPATOLOGY, 1992, 16 (01) :132-137
[4]  
BEASLEY RP, 1981, LANCET, V2, P1129
[5]   PREVALENCE OF CHRONIC LIVER-DISEASE IN THE GENERAL-POPULATION OF NORTHERN ITALY - THE DIONYSOS STUDY [J].
BELLENTANI, S ;
TIRIBELLI, C ;
SACCOCCIO, G ;
SODDE, M ;
FRATTI, N ;
DEMARTIN, C ;
CRISTIANINI, G ;
ARMOCIDA, C ;
BARBANI, A ;
BARONI, D ;
BRANDI, G ;
CROCE, LS ;
FERRETTI, I ;
FIGLIOLI, GF ;
MANENTI, AL ;
MANENTI, F ;
MARCHEGIANO, P ;
MESSORI, B ;
PASSAMONTI, S ;
POPPI, C ;
SASSATELLI, R .
HEPATOLOGY, 1994, 20 (06) :1442-1449
[6]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[7]   Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].
Bruix, J ;
Castells, A ;
Bosch, J ;
Feu, F ;
Fuster, J ;
GarciaPagan, JC ;
Visa, J ;
Bru, C ;
Rodes, J .
GASTROENTEROLOGY, 1996, 111 (04) :1018-1022
[8]  
Bruix J, 1997, HEPATOLOGY, V25, P259
[9]   Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children [J].
Chang, MH ;
Chen, CJ ;
Lai, MS ;
Hsu, HM ;
Wu, TC ;
Kong, MS ;
Liang, DC ;
Shau, WY ;
Chen, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (26) :1855-1859
[10]   Screening for hepatocellular carcinoma [J].
Collier, J ;
Sherman, M .
HEPATOLOGY, 1998, 27 (01) :273-278